{
    "code": "01047599",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01047599",
    "time": "2021-01-22 05:35:27",
    "許可證字號": "衛署藥製字第047599號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/10\/27",
    "發證日期": "94\/10\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "",
    "中文品名": "若通持續釋放膠囊0.2毫克",
    "英文品名": "Zotan S.R. Capsules 0.2mg",
    "適應症": "前列腺肥大症(增生)所伴隨的排尿障礙。",
    "劑型": "166持續性釋放膠囊",
    "包裝": "2-1000粒塑膠瓶裝 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TAMSULOSIN HYDROCHLORIDE",
    "限制項目": "24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口１８２之１號",
    "主製造廠": [
        {
            "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036710",
            "成分名稱": "TAMSULOSIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "0.2000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "A047599 In-104-10-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01047599&Seq=003&Type=9"
        },
        {
            "title": "010475990004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01047599&Seq=004&Type=8"
        }
    ]
}